Stock screenerAll disclosures →
EDGAR →
IMNM
Conviction 42HealthcareScan · Thu, Jun 25, 2026IMNM$19.39-1.82%
ResistanceSupportVol 14Insider buyInsider sell5
Vol MA14 1.64M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price19.39
Change-1.82%
Gap-0.94%
Rel volume2.19×
Avg volume1.58M
Avg $ vol30.43M
SMA 2019.27
SMA 5021.32
SMA 20019.53
Price vs 50-9.03%
Price vs 200-0.71%
MA stackmixed
50/200 cross—
Supertrenddown · 20.91
RSI (14)47
MACD hist0.21
MACD crossbull · 3d
Stoch %K / %D48 / 63
ADX (14)17
+DI / −DI29 / 19
RSI divergenceBullish
MACD divergenceBullish
ATR %+5.15%
ADR %4.71%
52w high26.97
52w low8.40
From 52w high-28.11%
Above 52w low+130.83%
New 52w highNo
SqueezeOff
Bollinger width24.96%
%B0.53
Donchian pos31.20%
Donchian high22.83
Donchian low17.83
AVWAP (52w high)21.34
vs AVWAP high-9.12%
AVWAP (52w low)18.60
vs AVWAP low+4.23%
OBV trendFlat
Chaikin MF (20)-0.23
Today vs 20d2.19×
Avg vol (14d)1.64M
Avg vol (20d)1.58M
Avg $ vol (20d)30.43M
Market cap2.2B
RS 3m (vs SPY)-14.53%
RS 6m (vs SPY)-15.62%
RS line new highNo
Trend template3/8
Technical rank29.2
1 week+4.64%
1 month-11.50%
3 months-4.48%
6 months-11.98%
1 year+117.38%
YTD-6.87%
P/E-10.34
P/B3.73
P/S316.37
P/FCF-10.95
EPS-2.43
Div yield—
ROE-36.08%
ROA-34.27%
Debt/Eq0.00
Current21.68
EV/EBITDA-7.28
Gross margin—
Net margin—
Rev growth-23.23%
EPS growth27.50%
Price target35.77
Target upside84.48%
Analyst ratingBuy
Institutional108.51%
Ent. value1.61B
Revenue0
Net income-53.84M
Gross profit—
Free cash flow-200.6M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out113.25M
Employees177
ListedFri, Oct 2, 2020
Free float77.44M
Float %84.4%
Short interest16.86M
Days to cover14.2d
Short volume20.1%
Squeeze score80 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.51 · 5 est
Last EPS vs est−$0.48 vs −$0.60
Last surprise+20.0% beat
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank29.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance24.00
Support18.64
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IMNM
No recent disclosed trades by Congress in IMNM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IMNM · 6 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BIENAIME JEAN JACQUES Director · Director Stock Option (right to buy) · 2026-06-10 | Grant | 9.9K | — | 2026-06-10 | 2026-06-12 |
Barchas Isaac Director · Director Stock Option (right to buy) · 2026-06-10 | Grant | 9.9K | — | 2026-06-10 | 2026-06-12 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-05 | Sell | 500 | $10K | 2026-06-05 | 2026-06-09 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-05 | Buy | 3.5K | $68K | 2026-06-05 | 2026-06-09 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-05 | Sell | 10K | $194K | 2026-06-05 | 2026-06-09 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-05 | Buy | 1K | $19K | 2026-06-05 | 2026-06-09 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-06-05 | Buy | 6K | $117K | 2026-06-05 | 2026-06-09 |
BIENAIME JEAN JACQUES Director · Common Stock · 2026-05-15 | Buy | 5K | $104K | 2026-05-15 | 2026-05-19 |
SEC filings
EDGAR filings in IMNM · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.